The Dronabinol Capsules, cataloged under National Stock Number 6505-01-650-3553, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Ascend Laboratories Llc Dba Ascend Laboratories Llc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-650-3553 |
| Primary Part Number | NDC67877-0755-60 |
| Item Name | Dronabinol Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Ascend Laboratories Llc Dba Ascend Laboratories Llc |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE III |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC67877-0755-60 PRIMARY | Ascend Laboratories Llc Dba Ascend Laboratories Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM152488 | 5/1 Secondary reference Defense Medical Standardization Board |
| NDC00591-3593-60 | 5/9 Secondary reference Actavis Pharma, Inc. |
| 1389523 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-650-3553 is a Dronabinol Capsules, manufactured by Ascend Laboratories Llc Dba Ascend Laboratories Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-650-3553 has 1 manufacturer part number on file: NDC67877-0755-60 (Ascend Laboratories Llc Dba Ascend Laboratories Llc).
Key specifications for NDC67877-0755-60: Controlled Substance Classification: SCHEDULE III; Special Features: DRONABINOL CAPSULES; RX ONLY, FOR ORAL ADMINISTRATION; DEA SCHEDULE III CONTROLLED SUBSTANCE; EACH CAPSULE CONTAINS: DRONABINOL 10 MG; STORE IAW PACKAGE INSERT; Part Name Assigned by Controlling Agency: MARINOL 10MG CAPSULE 60S. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.